These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11844699)

  • 1. CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines.
    Lynch CL; Gentry AL; Hale JJ; Mills SG; MacCoss M; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Doss G; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA
    Bioorg Med Chem Lett; 2002 Feb; 12(4):677-9. PubMed ID: 11844699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity.
    Hale JJ; Budhu RJ; Holson EB; Finke PE; Oates B; Mills SG; MacCoss M; Gould SL; DeMartino JA; Springer MS; Siciliano S; Malkowitz L; Schleif WA; Hazuda D; Miller M; Kessler J; Danzeisen R; Holmes K; Lineberger J; Carella A; Carver G; Emini E
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2741-5. PubMed ID: 11591514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV.
    Lynch CL; Hale JJ; Budhu RJ; Gentry AL; Mills SG; Chapman KT; MacCoss M; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):3001-4. PubMed ID: 12270193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor.
    Shankaran K; Donnelly KL; Shah SK; Guthikonda RN; MacCoss M; Mills SG; Gould SL; Malkowitz L; Siciliano SJ; Springer MS; Carella A; Carver G; Hazuda D; Holmes K; Kessler J; Lineberger J; Miller MD; Emini EA; Schleif WA
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3419-24. PubMed ID: 15177445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.
    Imamura S; Ishihara Y; Hattori T; Kurasawa O; Matsushita Y; Sugihara Y; Kanzaki N; Iizawa Y; Baba M; Hashiguchi S
    Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):63-73. PubMed ID: 14709870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element.
    Tagat JR; McCombie SW; Steensma RW; Lin S; Nazareno DV; Baroudy B; Vantuno N; Xu S; Liu J
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2143-6. PubMed ID: 11514156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains.
    Willoughby CA; Rosauer KG; Hale JJ; Budhu RJ; Mills SG; Chapman KT; MacCoss M; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA
    Bioorg Med Chem Lett; 2003 Feb; 13(3):427-31. PubMed ID: 12565944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chains.
    Lynch CL; Willoughby CA; Hale JJ; Holson EJ; Budhu RJ; Gentry AL; Rosauer KG; Caldwell CG; Chen P; Mills SG; MacCoss M; Berk S; Chen L; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA
    Bioorg Med Chem Lett; 2003 Jan; 13(1):119-23. PubMed ID: 12467630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
    Ali MA; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Samy JG; De Clercq E; Pannecouque C
    Acta Pol Pharm; 2011; 68(3):343-8. PubMed ID: 21648188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Configurationally restricted bismacrocyclic CXCR4 receptor antagonists.
    Valks GC; McRobbie G; Lewis EA; Hubin TJ; Hunter TM; Sadler PJ; Pannecouque C; De Clercq E; Archibald SJ
    J Med Chem; 2006 Oct; 49(21):6162-5. PubMed ID: 17034122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides.
    Palani A; Shapiro S; Clader JW; Greenlee WJ; Vice S; McCombie S; Cox K; Strizki J; Baroudy BM
    Bioorg Med Chem Lett; 2003 Feb; 13(4):709-12. PubMed ID: 12639564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection.
    Kim D; Wang L; Caldwell CG; Chen P; Finke PE; Oates B; MacCoss M; Mills SG; Malkowitz L; Gould SL; DeMartino JA; Springer MS; Hazuda D; Miller M; Kessler J; Danzeisen R; Carver G; Carella A; Holmes K; Lineberger J; Schleif WA; Emini EA
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3103-6. PubMed ID: 11720852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides.
    McCombie SW; Tagat JR; Vice SF; Lin SI; Steensma R; Palani A; Neustadt BR; Baroudy BM; Strizki JM; Endres M; Cox K; Dan N; Chou CC
    Bioorg Med Chem Lett; 2003 Feb; 13(3):567-71. PubMed ID: 12565973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents.
    Li B; Jones ED; Zhou E; Chen L; Baylis DC; Yu S; Wang M; He X; Coates JA; Rhodes DI; Pei G; Deadman JJ; Xie X; Ma D
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5334-6. PubMed ID: 20674358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activity.
    Hale JJ; Budhu RJ; Mills SG; MacCoss M; Gould SL; DeMartino JA; Springer MS; Siciliano SJ; Malkowitz L; Schleif WA; Hazuda D; Miller M; Kessler J; Danzeisen R; Holmes K; Lineberger J; Carella A; Carver G; Emini EA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2997-3000. PubMed ID: 12270192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors.
    Rudick JG; Laakso MM; Schloss AC; DeGrado WF
    Org Biomol Chem; 2013 Nov; 11(41):7096-100. PubMed ID: 24065278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New piperazinyl polyazacyclophane scaffolds, libraries and biological activities.
    An H; Haly BD; Cook PD
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2345-50. PubMed ID: 9873539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Kim JT; Hamilton AD; Bailey CM; Domaoal RA; Wang L; Anderson KS; Jorgensen WL
    J Am Chem Soc; 2006 Dec; 128(48):15372-3. PubMed ID: 17131993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New conformationally locked bicyclic N,O-nucleoside analogues of antiviral drugs.
    Procopio A; Alcaro S; De Nino A; Maiuolo L; Ortuso F; Sindona G
    Bioorg Med Chem Lett; 2005 Feb; 15(3):545-50. PubMed ID: 15664810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-AIDS agents. Part 47: Synthesis and anti-HIV activity of 3-substituted 3',4'-Di-O-(S)-camphanoyl-(3'R,4'R)-(+)-cis-khellactone derivatives.
    Xie L; Allaway G; Wild C; Kilgore N; Lee KH
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2291-3. PubMed ID: 11527717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.